Cannabinoids

What cannabinoids are, how THC, CBD, CBG, CBN, and CBC are categorized, and why modern cannabis profiles are more than just a single THC percentage.

Cannabinoids are the defining bioactive compounds of cannabis and are among the most important reasons why the plant is subject to such intense debate in medical, scientific, and cultural spheres.

In a narrower sense, this usually refers to the phytocannabinoids of the hemp plant. In a broader sense, however, the term also encompasses the body's own endocannabinoids as well as synthetic cannabinoids. All three groups are linked to the endocannabinoid system, yet they differ significantly in origin, effect profile, and risk assessment.

Plant-based cannabinoids are particularly relevant for cannabis. The most well-known are THC and CBD, but CBG, CBN, CBC, THCV, and other minor cannabinoids are also gaining importance.

What cannabinoids actually are

Cannabinoids are chemical compounds that dock onto components of the body's own endocannabinoid system or can influence it in other ways. In cannabis, they primarily originate in the glandular trichomes of the plant.

In the fresh flower, many cannabinoids exist initially in an acidic form, such as THCA or CBDA. It is only through further transformation, for example via heat, that they become the neutral forms THC and CBD, which are particularly well-known in everyday life.

Conceptual precision is important: not every cannabinoid is psychoactive, and not every cannabinoid acts primarily via the same mechanism. THC is the most famous intoxicating plant active ingredient. CBD, by contrast, is considered non-intoxicating and is often described as having a broader, less directly intoxicating effect profile.

Botanically and analytically, it is also important to note that cannabis does not produce only THC and CBD. Many strains carry complex cannabinoid patterns that differ significantly depending on genetics, breeding, maturity, and processing.

This is exactly where it becomes clear why trichomes and cannabinoids belong so closely together in the cannabis context. Those who want to understand where the decisive plant substances originate and why fresh flowers primarily carry acidic precursors will end up, almost automatically, at the glandular trichomes.

How cannabinoids act in the body

The central point of reference is the endocannabinoid system, or ECS for short. This system consists essentially of the CB1 and CB2 receptors, the body's own endocannabinoids anandamide and 2-arachidonoylglycerol (2-AG for short), as well as enzymes that synthesize and break down these messenger substances.

Its task is not to govern a single bodily function, but rather to regulate many processes related to balance and adaptation. These include neuronal signal processing, pain modulation, emotional regulation, immune responses, and metabolic processes.

CB1 receptors are found in particularly high concentrations in the central nervous system. Consequently, they are closely linked to perception, mood, memory, coordination, and the classic psychoactive profile of THC. CB2 receptors, on the other hand, are located primarily on immune cells and are more strongly associated with inflammation-related and immunological processes.

This simplified distinction is useful, even if research now shows that the endocannabinoid system is significantly more complex.

THC binds relatively directly to cannabinoid receptors, which accounts for a large part of its well-known central nervous system effects. CBD functions in a more complex manner. It does not have a classic THC-like intoxicating effect and is described in research more as a broad-acting modulator.

Overview of the most important cannabinoids

THC, or delta-9-tetrahydrocannabinol, is the most well-known psychoactive cannabinoid of the plant. It represents the classic intoxicating profile of cannabis and is, at the same time, one of the most thoroughly researched active ingredients in a medical context.

CBD, or cannabidiol, is the most well-known non-intoxicating primary cannabinoid. It is being widely researched and is strongly linked to medical, neurological, and regulatory issues. At the same time, general health claims for freely marketed CBD products should be clearly distinguished from licensed medicines.

CBG, or cannabigerol, is particularly interesting because its acidic precursor CBGA serves as the biosynthetic starting point for several other cannabinoid classes. This is why CBG is often referred to as the mother cannabinoid. CBN, or cannabinol, is usually discussed in the context of the aging and degradation processes of THC. CBC, meanwhile, is one of the less well-known, but pharmacologically interesting, minor cannabinoids.

For strain selection, this means: a high THC value alone says less today than it did in the past. Anyone selecting more precisely from the Cannaseuse assortment should also pay attention to the ratio of the primary cannabinoids, potential minor profiles, and the terpene profile.

Acidic precursors and decarboxylation

In fresh plant material, many cannabinoids initially exist as acidic precursors. THCA is the acidic precursor of THC, and CBDA is the acidic precursor of CBD. Chemically and pharmacologically, these forms are not simply identical to their neutral variants.

Decarboxylation can occur through heat, time, or processing. During this process, acidic cannabinoids lose a carboxyl group and are converted into neutral cannabinoids. In everyday life, this process is particularly associated with the activation of THC from THCA.

Cannabinoids do not work in isolation

In the world of cannabis, there is frequent talk of the so-called entourage effect. This refers to the idea that cannabinoids, terpenes, and other plant substances work together differently or, in some cases, more cohesively than isolated individual substances.

This concept is not scientifically unfounded, but it has also not been conclusively proven in every respect. It is therefore sensible to use a nuanced formulation: complementary effects are plausible and are a subject of discussion, but the clinical evidence base depends heavily on the combination of substances, the dosage, the product form, and the area of application.

In practice, this idea explains why two strains with similar THC content can be perceived very differently, and why full-spectrum, broad-spectrum, isolated cannabinoids, and different genetics cannot simply be equated.

Medicine, research, and real-world evidence

Cannabinoids are being researched intensively, but the data varies greatly depending on the area of application. For certain medicinal products and clearly defined indications, the evidence is significantly more robust than for general wellness or health claims.

It is important to distinguish between cannabis as a plant, individual approved cannabinoid-containing medicines, and freely marketed products. In the USA, for example, individual defined medicines are approved, while cannabis itself is not universally authorized as a treatment for all illnesses.

In Germany, too, medical cannabis is not classified as a random wellness product, but is regulated via the MedCanG and medical prescriptions. Medical cannabis thus remains a distinct area separate from the general cannabis law for adults.

Legal classification: THC, CBD, and Germany

The legal situation surrounding cannabinoids is significantly more complex than many simple summaries suggest. Since the implementation of the Cannabis Act in Germany, adults are permitted to possess cannabis to a limited extent and grow up to three plants privately. At the same time, the legal framework for products, distribution, advertising, and medical use remains nuanced.

The classification of CBD is often particularly misleading. CBD is not automatically legal simply because it does not have an intoxicating effect. The legal assessment always depends on the product category, composition, intended use, and the regulatory framework.

For Cannaseuse, this differentiation is important because it shows that cannabinoids are not just a matter of active ingredients, but also a matter of education and orientation. Anyone wishing to communicate seriously about strains, genetics, and product categories should not rely on sweeping health promises or simplified legality claims.

Cannabinoids from the Cannaseuse perspective

For Cannaseuse, cannabinoids are, above all, a key to reading cannabis strains more precisely. A strain is not just "strong" or "weak," but carries a specific chemical profile.

This profile arises from major cannabinoids, minor cannabinoids, acidic precursors, terpenes, genetics, maturity, and processing. This is exactly why a single percentage value is only a snapshot, not the whole story.

Anyone choosing cannabis consciously benefits from a curated perspective: do not look blindly for maximum THC, but understand genetics based on profile, aroma, structure, flowering time, growth, and desired character.

Discover genetics and cannabinoid profiles

FAQ – Frequently asked questions about cannabinoids

Conclusion

Cannabinoids are the chemical heart of cannabis. They do not determine everything, but they do define in a crucial way how a strain is classified, how it interacts with the endocannabinoid system, and why cannabis must be viewed in such a nuanced way in medicine, research, and the market.

THC and CBD are only at the tip of a much larger spectrum, which ranges from CBG and CBC to acidic precursors and minor profiles.

Back to top